GraphWear Technologies, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GraphWear Technologies, Inc. - overview
Established
2015
Location
San Francisco, CA, US
Primary Industry
Medical Devices & Equipment
About
GraphWear Technologies, Inc. is a health tech company specializing in non-invasive monitoring solutions, focusing on continuous glucose monitoring through innovative wearable technology for diabetes management. Founded in 2015 in San Francisco, US, GraphWear Technologies, Inc. develops non-invasive disease management solutions.
The company recently raised USD 20. 5 mn in Series B funding on October 5, 2021, led by Mayfield Fund, with participation from Builders VC, Mission BioCapital, and VSC Ventures. The company's CEO, Rajatesh Gudibande, co-founded GraphWear with Saurabh Radhakrishnan. The latest funding round was aimed at advancing clinical trials out of their San Francisco headquarters.
GraphWear Technologies Inc. specializes in non-invasive disease management solutions, primarily focusing on continuous glucose monitoring through wearable technology. Their flagship product utilizes advanced nanotechnology to measure glucose levels via sensors placed on the skin's surface, eliminating the need for traditional blood draws. This innovative approach enhances the quality of life for diabetes patients by providing real-time glucose monitoring without pain and targets applications such as hydration status assessment for athletes.
The technology caters to various geographical markets, including North America and Europe, ensuring broader access to its healthcare solutions. GraphWear generates revenue through partnerships and direct-to-consumer sales of its wearable glucose monitoring devices. The business model includes subscription services for continuous monitoring, where customers pay a recurring fee for access to the monitoring platform and data analytics. Partnerships with healthcare providers and fitness organizations facilitate bulk purchasing agreements, contributing to revenue generation.
The company’s investigational platform positions it competitively in the health tech market, with specific pricing plans designed for accessibility and value for both consumers and institutional clients. GraphWear Technologies, Inc. plans to use the USD 20. 5 mn raised in the latest funding round to advance clinical trials in San Francisco.
The company is focusing on launching new products that enhance non-invasive health monitoring solutions and expanding its reach into new markets in North America and Europe by the end of 2023.
Current Investors
Mission Bay Capital, Mission Biocapital, Mayfield Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Biomaterials, Nanomaterials
Website
www.graphwear.co
Verticals
Wearables & Quantified Self
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.